Malaria management - Progress made and challenges still to face

Malaria Journal

Volumn 8, Issue SUPPL. 1, 2009, Pages

  Ogutu, Bernhards R ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; GENERIC DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENDEMIC DISEASE; ETHIOPIA; HEALTH CARE ACCESS; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; ZAMBIA; DRUG COMBINATION; EDITORIAL; MALARIA;

ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA;

EID: 70350022408     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-S1-S1     Document Type: Article

References (13)

1. WHO Malaria Factsheet No. 95. Updated January 2009. http://www.who.int/ mediacentre/factsheets/fs094/en/index.html
2. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. M van Vugt P Wilairatana B Gemperli I Gathmann L Phaipun A Brockman C Luxemburger NJ White F Nosten S Looareesuwan, Am J Trop Med Hyg 1999 60 936 942 10403324
3. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. M van Vugt S Looareesuwan P Wilairatana R McGready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386 (Pubitemid 30793838)
4. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefèvre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop Med Hyg 2001 64 247 256 11463111
5. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial. S Abdulla I Sagara S Borrmann U D'Alessandro R Gonzlez M Hamel B Ogutu A Mårtensson J Lyimo H Maiga P Sasi A Nahum Q Bassat E Juma L Otieno A Björkman HP Beck K Andriano M Cousin G Lefèvre D Ubben Z Premji, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
6. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in non-immune populations: a safety, efficacy, and pharmacokinetic study. C Hatz J Soto HD Nothdurft T Zoller T Weitzel L Loutan F Bricaire F Gay GD Burchard K Andriano G Lefèvre PI De Palacios B Genton, Am J Trop Med Hyg 2008 78 241 247 18256423
7. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. CJ Sutherland R Ord S Dunyo M Jawara CJ Drakeley N Alexander R Coleman M Pinder G Walraven GA Targett, PLoS Med 2005 4 92 10.1371/journal.pmed.0020092 (Pubitemid 40721079)
8. Evidence of substantial nationwide reduction of malaria cases and deaths due to scale-up of malaria control activities in Zambia, 2001-2008. E Chizema-Kawesha V Mukonka M Mwanza C Kaliki M Phiri J Miller R Komatsu M Aregawi F Masaninga S Kitikiti O Babaniyi M Otten, World Health Organization, Zambia 19-23 January. Impact Evaluation Mission Report
9. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. P Chanda F Masiye BM Chitah N Sipilanyambe M Hawela P Banda T Okorosobo, Malar J 2007 6 21 17313682 10.1186/1475-2875-6-21 (Pubitemid 46303887)
10. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. KI Barnes DN Durrheim F Little, PLoS Med 2005 2 330 16187798 10.1371/journal.pmed.0020330 (Pubitemid 41735780)
11. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. K Barnes P Chanda GA Barnabas, Malar J 2009 8 Suppl 1 8
12. Community-level deployment of artemether lumefantrine (AL) with rapid diagnostic testing: effect on malaria outcomes and resource utilization in a rural setting [abstract]. H Lemma A Desta E Fottrell GA Barnabas A Bianchi A Bosman P Byass G Costanzo A Morrone N Mulure L Toma, Am J Trop Med Hyg 2008 79 51
13. INDEPTH Network. http://www.indepth-network.org/